NorthStar Asset Management (New Jersey)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,316
Closed -$234K 109
2026
Q1
$234K Sell
8,316
-277
-3% -$7.38K 0.11% 86
2025
Q4
$214K Sell
8,593
-330
-4% -$8.32K 0.1% 103
2025
Q3
$227K Sell
8,923
-97
-1% -$2.39K 0.11% 91
2025
Q2
$219K Sell
9,020
-326
-3% -$7.6K 0.12% 89
2025
Q1
$237K Sell
9,346
-33
-0.4% -$864 0.15% 76
2024
Q4
$249K Sell
9,379
-2,747
-23% -$74.5K 0.16% 72
2024
Q3
$351K Buy
12,126
+525
+5% +$15.3K 0.23% 59
2024
Q2
$325K Buy
11,601
+3,005
+35% +$82.7K 0.23% 60
2024
Q1
$239K Buy
8,596
+289
+3% +$8.02K 0.18% 70
2023
Q4
$239K Buy
+8,307
New +$251K 0.22% 68

Other funds holding PFE

NorthStar Asset Management (New Jersey)'s PFE Position: Q2 2026 in Review

NorthStar Asset Management (New Jersey) sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,316 shares — an estimated $234K sold.

NorthStar Asset Management (New Jersey) first reported a position in PFE in Q4 2023 and held it in 10 quarters. The position peaked at $351K in Q3 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • NorthStar Asset Management (New Jersey) reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • NorthStar Asset Management (New Jersey) sold 8,316 Pfizer shares in Q2 2026, an estimated $234K.
  • NorthStar Asset Management (New Jersey) first reported a position in Pfizer in Q4 2023 and held it in 10 quarters.
  • NorthStar Asset Management (New Jersey)'s Pfizer position peaked at $351K in Q3 2024.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q2 2026, filed 5 Aug 2026.